Pharmacytimes: Condition Center: Pain Management http://www.pharmacytimes.com/condition-resources/pain/condition-rss Pain Management en-us Wed, 28 Jun 2017 05:16:22 UTC Wed, 28 Jun 2017 05:16:22 UTC Opioid Use and Rheumatoid Arthritis Treatment: How Has Use Changed? http://www.pharmacytimes.com/resource-centers/pain/opioid-use-and-rheumatoid-arthritis-treatment-how-has-use-changed The opioid crisis is a major concern worldwide, with overdoses accounting for the number 1 cause of accidental deaths in the United States. 11:11 AM, Sat June 24, 2017 Should Dose Capping Parenteral Ketorolac Be the Standard? http://www.pharmacytimes.com/contributor/alexander-kantorovich-pharmd-bcps/2017/06/should-dose-capping-parenteral-ketorolac-be-the-standard- Like other non-steroidal anti-inflammatory drugs (NSAIDs), ketorolac works on cyclooxygenase enzymes (COX) and inhibits prostaglandin synthesis. 9:05 PM, Wed June 14, 2017 A Guide For Choosing An Appropriate NSAID http://www.pharmacytimes.com/contributor/nicole-leimbach-pharmd/2017/06/a-guide-for-choosing-an-appropriate-nsaid Due to the increasing rise in drug abuse from opioids and recent safety warnings regarding NSAIDs, practitioners are beginning to show more interest in topical agents. 9:43 PM, Thu June 1, 2017 Pain Management in End-Stage Renal Disease http://www.pharmacytimes.com/publications/health-system-edition/2017/May2017/pain-management-in-endstage-renal-disease <p>Recently we have received an increasing number of requests for consults on patients undergoing hemodialysis (HD) or with end-stage renal disease (ESRD). &nbsp;</p> 9:06 AM, Thu May 18, 2017 Potential Impact of the AHCA on OTCs http://www.pharmacytimes.com/contributor/shelby-leheny-pharmd-candidate-2017/2017/05/potential-impact-of-the-ahca-on-otcs OTC medications are typically not covered making them unaffordable and less accessible to the majority of the population. 8:59 AM, Tue May 16, 2017 Could Beer Be the Answer to Future Novel Pain Therapies? http://www.pharmacytimes.com/news/could-beer-be-the-answer-to-future-novel-pain-therapies Having a few alcoholic beverages may be just as effective as some pain medications from the pharmacy, according to research from a new study.&nbsp; 10:17 AM, Fri May 12, 2017 Treatment of Neuropathic Pain http://www.pharmacytimes.com/publications/health-system-edition/2017/March2017/treatment-of-neuropathic-pain Chronic pain has been defined by the International Association for the Study of Pain as pain that persists beyond the normal tissue healing time of 3 months, and it may be classified into 3 distinct categories: nociceptive, neuropathic, and a mixture of the two. 4:14 PM, Sun April 16, 2017 Intensive Outpatient Pain Management Cost-Effective for Treating Patients with Chronic Pain http://www.pharmacytimes.com/resource-centers/pain/intensive-outpatient-pain-management-shown-as-costeffective-for-treating-patients-with-chronic-pain- An interdisciplinary treatment modality is especially effective when treating patients with chronic pain. 2:03 PM, Mon March 20, 2017 Pain Management in End Stage Renal Disease http://www.pharmacytimes.com/contributor/jeffrey-fudin/2017/02/pain-management-in-end-stage-renal-disease Prescribers and pharmacists in various clinical roles are often challenged when treating patients with comorbid chronic pain and end-stage renal disease (ESRD) or hemodialysis (HD). There is a dearth of clinical guidelines available for chronic pain management in this setting. Those selecting pharmacotherapy for patients must rely on clinical judgement, literature analysis and prudent decision making. 11:51 PM, Sun February 26, 2017 New Jersey Enacts Strict Opioid Prescribing Law http://www.pharmacytimes.com/contributor/timothy-o-shea/2017/02/new-jersey-enacts-strict-opioid-prescribing-law On February 15 2017, Governor Chris Christie of New Jersey signed legislation aimed to curb the state’s opioid addiction epidemic 8:43 PM, Mon February 20, 2017 Patient Opioid Abuse Could Depend on ER Physician http://www.pharmacytimes.com/resource-centers/pain/patient-opioid-abuse-could-depend-on-er-physician A new study published today in <em>The New England Journal of Medicine </em>casts new light on the severity of the opioid abuse crisis in the United States. Nearly one out of 48 people who are newly prescribed an opioid will become long-term users, the study&rsquo;s lead author said. &nbsp;<br /> &nbsp; 3:09 PM, Thu February 16, 2017 Study: Yoga Provides Relief for Low Back Pain http://www.pharmacytimes.com/resource-centers/pain/study-yoga-provides-relief-for-low-back-pain <p>Yoga performed about the same as non-yoga exercise in terms of improving back function at 3 and 6 months, although the researchers found few studies comparing yoga to other exercise and therefore considered the evidence to be very low certainty.</p> 12:26 PM, Mon February 13, 2017 Patient Counseling: Most Important Opioid Warnings http://www.pharmacytimes.com/contributor/steve-leuck-pharmd/2017/01/patient-counseling-most-important-opioid-warnings Before you read this article, take a moment and see if you remember the 7 or 8 black box warnings associated with long acting opioid pain medications. 4:33 AM, Mon January 30, 2017 Pain in Patients with Cancer: Part 2 http://www.pharmacytimes.com/publications/health-system-edition/2017/January2017/pain-in-patients-with-cancer-part-2 Sixty percent to 90% of patients with cancer with bone metastasis develop bone pain.&nbsp;In turn, bone pain can be the first sign that cancer has spread to the bone. 4:27 PM, Sat January 14, 2017 Elite Files Application for Generic Hydrocodone, Acetaminophen Combination http://www.pharmacytimes.com/product-news/elite-files-application-for-generic-hydrocodone-acetaminophen-combination- Officials with Elite Pharmaceuticals have filed an abbreviated new drug application with the FDA for a generic version of Norco (hydrocodone bitartrate and acetaminophen tablets) in doses of 2.5 mg/325 mg, 5 mg/325 mg, 7.5 mg/325 mg and 10 mg/325 mg. 1:00 AM, Wed December 21, 2016 AcelRX Submits NDA to FDA for Investigational Pain Product http://www.pharmacytimes.com/product-news/acelrx-submits-nda-to-fda-for-investigational-pain-product- AcelRX has submitted&nbsp;a New Drug Application (NDA) to the FDA for ARX-04 (sufentanil tablets). 9:40 AM, Tue December 13, 2016 Pharmacists Have Role to Play in Minimizing Fall Risk http://www.pharmacytimes.com/news/pharmacists-have-role-to-play-in-minimizing-fall-risk Falls can cause significant mortality and morbidity in the aging population. 8:31 AM, Tue December 13, 2016 Egalet Submits sNDA to the FDA for Abuse-Deterrent Oxaydo http://www.pharmacytimes.com/product-news/egalet-submits-snda-to-the-fda-for-abusedeterrent-oxaydo Egalet has submitted&nbsp;a supplemental new drug application (sNDA) to the FDA for Oxaydo, (oxycodone HCl, USP) in favor of an abuse-deterrent label claim for the intravenous route of abuse. 9:49 AM, Thu December 1, 2016 Pain in Patients with Cancer http://www.pharmacytimes.com/publications/health-system-edition/2016/November2016/pain-in-patients-with-cancer Pain is an important concern for patients with cancer, although not every patient with cancer will experience pain. 3:19 PM, Tue November 22, 2016 Pain Medications, Part 2 http://www.pharmacytimes.com/publications/issue/2016/October2016/Pain-Medications-Part-2 How can you help a patient prepare for the additional medication costs and lifestyle challenges he may be facing? 5:30 AM, Tue October 18, 2016